Anti-Infective Drugs Market - Forecast(2021 - 2026)

Report Code: HCR 0149 Report Format: PDF + Excel (Delivery in 48 Hrs)

Anti-Infective Drugs Market Overview

Anti-Infective Drugs Market size is $108.8Bn in 2019, growing at a CAGR of 4.1% during the forecast period 2020-2025. Anti-Infective Drugs are medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright. This term includes antibiotics, antifungals, anthelmintics, antimalarials, antiprotozoals, antituberculosis agents, and antivirals. It treats minor infections and most often cure many serious infectious diseases, like pneumonia or tuberculosis. The anti-infective agents have distinct mechanism of action which includes the inhibition of DNA synthesis and kill the cellular component hence prevent it from replication. The increasing population of viral infections such as respiratory syncytial virus as well as influenza and high adoption of anti-infective therapies is driving the growth of the market.

Report Coverage

The report: “Anti-Infective Drugs Market – Forecast (2020-2025)”, by IndustryARC covers an in-depth analysis of the following segments of the Anti-Infective Drugs Market. 
By Drug Type: Antifungals – Allylamines, Azoles, Polyene Macrolides and Others, Antibacterials – Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines and Others, Antivirals - Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors, Protease Inhibitors and Others.
By Route of Administration: Oral, Topical, Parenteral and Others.
By Indication: HIV Infections, Pneumonia, Hepatitis, Influenza, Herpes Simplex and Others.
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Specialty Pharmacy, E-Commerce and Others.
By Geography: North America, Europe, Asia-Pacific and Rest of the World.

Key Takeaways

  • The increasing prevalence of diseases like malaria, chikungunya, and chagas disease is likely to be the major driving factor for the market’s growth.
  • Rise in the number of hospitals and primary care clinics are adding towards the market’s growth.
  • Asia-Pacific region is set to record the fastest growth rate during the forecast period 2020-2025.

By Indication - Segment Analysis

In 2019, HIV Infections segment dominated the Anti-Infective Drugs Market in terms of revenue is estimated to grow at a CAGR of 5.2%. It is an infectious virus that damages the cells in your immune system and weakens the ability to fight everyday infections and disease. HIV spreads through unprotected sex with an infected person and spread by sharing drug needles or through contact with the blood of a person who has HIV. HIV harms the immune system by destroying the white blood cells that fight infection. The increasing access to effective HIV prevention, diagnosis, treatment, and care, including for opportunistic infections, it has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives. According to WHO, in 2019, 68% of adults and 53% of children living with HIV globally were receiving lifelong antiretroviral therapy (ART) abetting towards the growth of the market.

By Geography - Segment Analysis

In 2019, the North America region dominated Anti-Infective Drugs Market in terms of revenue with a market share of more than 34% owing towards well-spread awareness of anti-infective drugs among end-users such as health care professionals and clinicians coupled with the presence of developed health care infrastructure in the region. Several government initiatives and high awareness in developed geographies including the U.S., private partnership projects and rising cost containment initiatives by drug manufacturers are the other factors augmenting the market growth. Major players are focusing on the development of new drugs for the treatment of HIV and other infectious diseases in this region, therefor, are the key factors in the growth of the Anti-Infective Drugs market. Asia-Pacific is projected to record the fastest growth rate during the forecast period 2020-2025. 

Drivers – Anti-Infective Drugs Market

  • Rising R&D Initiatives

The programs like Innovative Medicines Initiative’s (IMI’s), New Drugs for Bad Bugs (ND4BB) program, Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), and Biomedical Advanced Research and Development Authority’s (BARDA) Broad Spectrum Antimicrobials Program have been implemented for the development of novel antibiotics by focusing on R&D gaps. Similarly, Global Antibiotic Research and Development Partnership (GARDP) set up by the World Health Organization (WHO) and the Drugs for Neglected Diseases Initiative (DNDi) in May 2016 is further providing support to the R&D initiatives globally thereby propelling the Anti-Infective drugs market.

Challenges – Anti-Infective Drugs Market

  • Supply Shortages of Anti-Infective Drugs

The shortage of supply for anti-infective drugs can be attributed to low profits margins in the industry and exit strategies adopted by the market players is anticipated restrains the market’s growth. Also, major antibiotics companies such as Novartis, AstraZeneca and others are paying less attention on their antibiotic research operations owing to the lack of profitability, which further results in the shortage of drugs and thus hampering the anti-infective drugs market.

Anti-Infective Drugs Industry Outlook 

Product Launches was the key strategy of the players in the Anti-Infective Drugs Industry. Anti-Infective Drugs top 10 companies include Abbott Laboratories, Alcon Pharmaceuticals Ltd., Quest Diagnostics Inc., AstraZeneca Plc., Bayer HealthCare AG, Bristol-Myers Squibb Co., Boehringer Ingelheim, Sanofi-Aventis SA, Novartis AG and GlaxoSmithKline Plc.

Acquisitions/Product Launches

  • In January 2020, Novartis AG acquired The Medicines Company. This acquisition helped in the treatment of the world’s leading cause of mortality and disability with a vaccine-like approach. 
  • In May 2016, Quest Diagnostics Inc. launched three new cancer test (MYvantage™ 34-gene Hereditary, GIvantage™ Hereditary and Qvantage™ Hereditary) services designed to provide clinically actionable insight into an individual's risk of developing hereditary forms of cancer.
1. Anti-Infective Drugs Market Overview
    1.1 Definitions and Scope
2. Anti-Infective Drugs Market - Executive Summary 
    2.1 Market Revenue, Market Size and Key Trends 
    2.2 Key trends by Drug Type
    2.3 Key trends by Route of Administration
    2.4 Key trends by Indication
    2.5 Key rends by Geography
3. Anti-Infective Drugs Market 
    3.1 Market Share Analysis
    3.2 Comparative Analysis
        3.2.1 Product Benchmarking – Key Companies
        3.2.2 Patent Analysis
        3.2.3 Pricing Analysis
        3.2.4 Financial Analysis– Key Companies
4. Anti-Infective Drugs Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Anti-Infective Drugs Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Anti-Infective Drugs Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Anti-Infective Drugs Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Anti-Infective Drugs Market – By Drug Type (Market Size –$Million/$Billion)
    8.1 Antifungals
        8.1.1 Allylamines
        8.1.2 Azoles
        8.1.3 Polyene Macrolides
        8.1.4 Others
    8.2 Antibacterials
        8.2.1 Aminoglycosides
        8.2.2 Carbapenems
        8.2.3 Cephalosporins
        8.2.4 Macrolides
        8.2.5 Penicillins
        8.2.6 Quinolones
        8.2.7 Sulfonamides
        8.2.8 Tetracyclines
        8.2.9 Others
    8.3 Antivirals
        8.3.1 Nucleoside Analogs
        8.3.2 Transcriptase Inhibitors
        8.3.3 DNA Polymerase Inhibitors
        8.3.4 Protease Inhibitors
        8.3.5 Other
9. Anti-Infective Drugs Market – By Route of Administration (Market Size –$Million/$Billion)
    9.1 Oral
    9.2 Topical
    9.3 Parenteral 
    9.4 Others
10. Anti-Infective Drugs Market – By Indication (Market Size –$Million/$Billion)
    10.1 HIV Infections
    10.2 Pneumonia 
    10.3 Hepatitis
    10.4 Influenza
    10.5 Herpes Simplex
    10.6 Others
11. Anti-Infective Drugs Market – By Distribution Channel (Market Size –$Million/$Billion) 
    11.1 Hospital Pharmacy
    11.2 Retail Pharmacy
    11.3 Specialty Pharmacy
    11.4 E-Commerce
    11.5 Others
12. Anti-Infective Drugs Market - By Geography (Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 Rest of the World
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Anti-Infective Drugs Market - Entropy
14. Anti-Infective Drugs Market – Industry/Segment Competition Landscape Premium 
    14.1 Market Share Analysis
        14.1.1 Market Share by Region – Key companies
        14.1.2 Market Share by Countries – Key Companies
        14.1.3 Best Practices for Companies
15. Anti-Infective Drugs Market – Key Company List by Country Premium Premium
16. Anti-Infective Drugs Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1: Anti-Infective Drugs Market Overview 2019-2024
Table 2: Anti-Infective Drugs Market Leader Analysis 2018-2019 (US$)
Table 3: Anti-Infective Drugs Market Product Analysis 2018-2019 (US$)
Table 4: Anti-Infective Drugs Market End User Analysis 2018-2019 (US$)
Table 5: Anti-Infective Drugs Market Patent Analysis 2013-2018* (US$)
Table 6: Anti-Infective Drugs Market Financial Analysis 2018-2019 (US$)
Table 7: Anti-Infective Drugs Market Driver Analysis 2018-2019 (US$)
Table 8: Anti-Infective Drugs Market Challenges Analysis 2018-2019 (US$)
Table 9: Anti-Infective Drugs Market Constraint Analysis 2018-2019 (US$)
Table 10: Anti-Infective Drugs Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Anti-Infective Drugs Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Anti-Infective Drugs Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Anti-Infective Drugs Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Anti-Infective Drugs Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Anti-Infective Drugs Market Value Chain Analysis 2018-2019 (US$)
Table 16: Anti-Infective Drugs Market Pricing Analysis 2019-2024 (US$)
Table 17: Anti-Infective Drugs Market Opportunities Analysis 2019-2024 (US$)
Table 18: Anti-Infective Drugs Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Anti-Infective Drugs Market Supplier Analysis 2018-2019 (US$)
Table 20: Anti-Infective Drugs Market Distributor Analysis 2018-2019 (US$)
Table 21: Anti-Infective Drugs Market Trend Analysis 2018-2019 (US$)
Table 22: Anti-Infective Drugs Market Size 2018 (US$)
Table 23: Anti-Infective Drugs Market Forecast Analysis 2019-2024 (US$)
Table 24: Anti-Infective Drugs Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 26: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Antifungals, 2019-2024 ($)
Table 27: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Allylamines, 2019-2024 ($)
Table 28: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Antibacterials, 2019-2024 ($)
Table 29: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Aminoglycosides, 2019-2024 ($)
Table 30: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Antivirals, 2019-2024 ($)
Table 31: Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 32: Anti-Infective Drugs Market By Infection, Revenue & Volume,By HIV, 2019-2024 ($)
Table 33: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Hepatitis B, 2019-2024 ($)
Table 34: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Hepatitis C, 2019-2024 ($)
Table 35: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Urinary Tract, 2019-2024 ($)
Table 36: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Respiratory Candidiasis, 2019-2024 ($)
Table 37: North America Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 38: North America Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 39: South america Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 40: South america Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 41: Europe Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 42: Europe Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 43: APAC Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 44: APAC Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 45: Middle East & Africa Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 46: Middle East & Africa Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 47: Russia Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 48: Russia Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 49: Israel Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2019-2024 ($)
Table 50: Israel Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2019-2024 ($)
Table 51: Top Companies 2018 (US$)Anti-Infective Drugs Market, Revenue & Volume
Table 52: Product Launch 2018-2019Anti-Infective Drugs Market, Revenue & Volume
Table 53: Mergers & Acquistions 2018-2019Anti-Infective Drugs Market, Revenue & Volume


List of Figures

Figure 1: Overview of Anti-Infective Drugs Market 2019-2024
Figure 2: Market Share Analysis for Anti-Infective Drugs Market 2018 (US$)
Figure 3: Product Comparison in Anti-Infective Drugs Market 2018-2019 (US$)
Figure 4: End User Profile for Anti-Infective Drugs Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Anti-Infective Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Anti-Infective Drugs Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Anti-Infective Drugs Market 2018-2019
Figure 8: Ecosystem Analysis in Anti-Infective Drugs Market 2018
Figure 9: Average Selling Price in Anti-Infective Drugs Market 2019-2024
Figure 10: Top Opportunites in Anti-Infective Drugs Market 2018-2019
Figure 11: Market Life Cycle Analysis in Anti-Infective Drugs Market
Figure 12: GlobalBy Drugs TypeAnti-Infective Drugs Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy InfectionAnti-Infective Drugs Market Revenue, 2019-2024 ($)
Figure 14: Global Anti-Infective Drugs Market - By Geography
Figure 15: Global Anti-Infective Drugs Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Anti-Infective Drugs Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 18: US Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 93: China Anti-Infective Drugs Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Anti-Infective Drugs Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Anti-Infective Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Anti-Infective Drugs Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Anti-Infective Drugs Market 
Figure 131: Developments, 2018-2019*Anti-Infective Drugs Market 
Figure 132: Company 1 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)